{"organizations": [], "uuid": "808a15be37f77a987403f8151a4d4930a3d3724f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://images.wsj.net/im-3473/social", "site_section": "http://www.wsj.com/xml/rss/3_7014.xml", "section_title": "WSJ.com: US Business", "url": "https://www.wsj.com/articles/fda-approval-of-23andme-kit-is-latest-example-of-agencys-course-reversal-1520591400", "country": "US", "domain_rank": 387, "title": "At-Home Cancer-Risk Test Opens New—and Fraught—Field", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-09T12:30:00.000+02:00", "replies_count": 0, "uuid": "808a15be37f77a987403f8151a4d4930a3d3724f"}, "author": "Thomas M. Burton", "url": "https://www.wsj.com/articles/fda-approval-of-23andme-kit-is-latest-example-of-agencys-course-reversal-1520591400", "ord_in_thread": 0, "title": "At-Home Cancer-Risk Test Opens New—and Fraught—Field", "locations": [], "entities": {"persons": [], "locations": [{"name": "washington", "sentiment": "none"}], "organizations": [{"name": "23andme inc.", "sentiment": "none"}, {"name": "food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "WASHINGTON—Federal health officials this week allowed a genetic testing firm to sell kits to consumers to test whether they carry gene mutations that put them at higher risk for breast and ovarian cancer.\nThe action, part of a broader regulatory shift, is the first time the Food and Drug Administration has allowed a company—in this case 23andMe Inc.—to market such a cancer-risk test directly to the public.\n\nIt... RELATED VIDEO Why China Is Rushing to Collect Genes Seeking new ways to treat diseases including cancer and diabetes, scientists around the world are gathering gene samples for study. China is betting it can map citizens' genes and build up a database faster than anyone else. Photo: Shawn Koh for The Wall Street Journal  ", "external_links": [], "published": "2018-03-09T12:30:00.000+02:00", "crawled": "2018-03-09T15:10:37.004+02:00", "highlightTitle": ""}